Michael Bolinder
Chief Executive Officer chez ACACIA PHARMA GROUP PLC
Profil
Michael Bolinder is the CEO of Acacia Pharma Group Ltd.
since 2019.
Prior to this, he worked as Head of Marketing & Commercial Strategy at Mallinckrodt Pharmaceuticals Ltd.
from 2013 to 2015.
He completed his undergraduate degree from Florida State University.
Postes actifs de Michael Bolinder
Sociétés | Poste | Début |
---|---|---|
ACACIA PHARMA GROUP PLC | Chief Executive Officer | 01/08/2019 |
Anciens postes connus de Michael Bolinder
Sociétés | Poste | Fin |
---|---|---|
Mallinckrodt Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Pharmaceuticals Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The private company is based in Staines Upon Thames, UK and was founded in 2015. | Sales & Marketing | 01/08/2015 |
Formation de Michael Bolinder
Florida State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Acacia Pharma Group Ltd.
Acacia Pharma Group Ltd. Pharmaceuticals: OtherHealth Technology Acacia Pharma Group Plc is a holding company, which engages in the development and commercialization of pharmaceutical product. It focuses on the new nausea and vomiting treatments for surgical and cancer patients. The company was founded by Julian Clive Gilbert, Robert William Gristwood, and Andrew Muncey in 2007 and is headquartered in Duxford, the United Kingdom. | Health Technology |
Mallinckrodt Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Pharmaceuticals Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The private company is based in Staines Upon Thames, UK and was founded in 2015. | Health Technology |